143 related articles for article (PubMed ID: 19577898)
41. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
[TBL] [Abstract][Full Text] [Related]
42. Prevention of venous thromboembolic complications with and without intermittent pneumatic compression in neurosurgical cranial procedures using intraoperative magnetic resonance imaging. A retrospective analysis.
Frisius J; Ebeling M; Karst M; Fahlbusch R; Schedel I; Gerganov V; Samii A; Lüdemann W
Clin Neurol Neurosurg; 2015 Jun; 133():46-54. PubMed ID: 25837574
[TBL] [Abstract][Full Text] [Related]
43. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty.
Husted H; Otte KS; Kristensen BB; Ørsnes T; Wong C; Kehlet H
Acta Orthop; 2010 Oct; 81(5):599-605. PubMed ID: 20919815
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of venous thromboembolism after hip and knee replacement surgery.
O'Reilly RF; Burgess IA; Zicat B
Med J Aust; 2005 Feb; 182(4):154-9. PubMed ID: 15720169
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
Liu J; Zhao J; Yan Y; Su J
Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
Keeney JA; Clohisy JC; Curry MC; Maloney WJ
J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
[TBL] [Abstract][Full Text] [Related]
47. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
Yokote R; Matsubara M; Hirasawa N; Hagio S; Ishii K; Takata C
J Bone Joint Surg Br; 2011 Feb; 93(2):251-6. PubMed ID: 21282767
[TBL] [Abstract][Full Text] [Related]
48. [Prevention of thrombosis in hip prosthesis implantation].
Böttner F; Sculco TP; Sharrock NE; Westrich GH; Steinbeck J
Orthopade; 2001 Nov; 30(11):890-6. PubMed ID: 11766633
[TBL] [Abstract][Full Text] [Related]
49. Proximal deep vein thrombosis after hip replacement for oncologic indications.
Nathan SS; Simmons KA; Lin PP; Hann LE; Morris CD; Athanasian EA; Boland PJ; Healey JH
J Bone Joint Surg Am; 2006 May; 88(5):1066-70. PubMed ID: 16651581
[TBL] [Abstract][Full Text] [Related]
50. Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients.
Ishibe M; Kariya S
Hip Int; 2011; 21(6):684-7. PubMed ID: 22101618
[TBL] [Abstract][Full Text] [Related]
51. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Bawa H; Weick JW; Dirschl DR; Luu HH
J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
[TBL] [Abstract][Full Text] [Related]
52. Venous thromboembolic disease after hybrid hip arthroplasty with negative duplex screening.
Beuhler KO; D'Lima DD; Colwell CW; Otis SM; Walker RH
Clin Orthop Relat Res; 1999 Apr; (361):168-77. PubMed ID: 10212610
[TBL] [Abstract][Full Text] [Related]
53. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
54. Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.
Kwak HS; Cho JH; Kim JT; Yoo JJ; Kim HJ
Clin Orthop Surg; 2017 Mar; 9(1):37-42. PubMed ID: 28261425
[TBL] [Abstract][Full Text] [Related]
55. Evidence-based evaluation of preoperative vs postoperative use of low-molecular-weight heparin in preventing deep vein thrombosis in elective hip surgery.
Ghosh A
Arch Intern Med; 1999 Jul; 159(14):1622-3. PubMed ID: 10421287
[No Abstract] [Full Text] [Related]
56. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Ghali WA; Butcher MS; Brant RF; Bergqvist D; Hamulyák K; Francis CW; Marder VJ; Raskob GE
Arch Intern Med; 2001 Sep; 161(16):1952-60. PubMed ID: 11525697
[TBL] [Abstract][Full Text] [Related]
57. Simple, hybrid deep venous thrombosis/pulmonary embolus prophylaxis after total hip arthroplasty.
Ward WG; Olin MD
J South Orthop Assoc; 1999; 8(1):14-9. PubMed ID: 12132847
[TBL] [Abstract][Full Text] [Related]
58. Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.
Kim YH; Park JW; Kim JS
J Arthroplasty; 2017 Feb; 32(2):641-644. PubMed ID: 27614816
[TBL] [Abstract][Full Text] [Related]
59. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
60. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight heparin in combination with intermittent pneumatic compression.
Silbersack Y; Taute BM; Hein W; Podhaisky H
J Bone Joint Surg Br; 2004 Aug; 86(6):809-12. PubMed ID: 15330019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
